Calip, Gregory S. http://orcid.org/0000-0002-7744-3518
Kidd, John
Bernhisel, Ryan
Cox, Hannah C.
Saam, Jennifer
Rauscher, Garth H.
Lancaster, Johnathan M.
Hoskins, Kent F.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2TR002002)
Article History
Received: 30 July 2020
Accepted: 2 September 2020
First Online: 11 September 2020
Compliance with ethical standards
:
: Mr. Kidd, Mr. Bernhisel, Dr. Cox, Mr. Evans, Dr. Saam and Dr. Lancaster received salary support and have ownership interest (stock options) in Myriad Genetics Laboratories, Inc. At the time of submission, Dr. Calip reports current employment with Flatiron Health, Inc., which is an independent subsidiary of the Roche group. Dr. Calip and Dr. Hoskins report receiving research support from Pfizer, Inc. for work unrelated to this project. Dr. Rauscher declares he has no conflict of interest.
: The study was performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The University of Illinois at Chicago Institutional Review Board (IRB), Chicago, IL approved the study (IRB Protocol # 2015–1176). The need for informed consent was waived under the approval of the IRB due to the retrospective design.